HomeGUD • TSE
add
Knight Therapeutics Inc
Nakaraang pagsara
$6.08
Sakop ng araw
$6.05 - $6.18
Sakop ng taon
$5.09 - $6.45
Market cap
608.08M CAD
Average na Volume
68.88K
P/E ratio
143.53
Dividend yield
-
Primary exchange
TSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CAD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 96.86M | 30.55% |
Gastos sa pagpapatakbo | 43.31M | 26.28% |
Net na kita | 10.74M | 144.13% |
Net profit margin | 11.08 | 133.79% |
Kita sa bawat share | 0.11 | 175.39% |
EBITDA | 6.46M | -17.88% |
Aktuwal na % ng binabayarang buwis | -36.32% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CAD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 172.84M | 1.75% |
Kabuuang asset | 963.80M | 1.94% |
Kabuuang sagutin | 168.69M | -15.07% |
Kabuuang equity | 795.10M | — |
Natitirang share | 100.05M | — |
Presyo para makapag-book | 0.76 | — |
Return on assets | -0.77% | — |
Return on capital | -0.88% | — |
Cash Flow
Net change in cash
| (CAD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 10.74M | 144.13% |
Cash mula sa mga operasyon | 1.47M | -91.81% |
Cash mula sa pag-invest | 18.05M | 1,049.45% |
Cash mula sa financing | -15.35M | 56.99% |
Net change in cash | 6.35M | 134.04% |
Malayang cash flow | 4.96M | -91.80% |
Tungkol
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Itinatag
2014
Headquarters
Website
Mga Empleyado
745
